These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 24450538)
41. Is shift work making your patient sick? Emerging theories and therapies for treating shift work disorder. Rosenberg R; Doghramji PP Postgrad Med; 2011 Sep; 123(5):106-15. PubMed ID: 21904092 [TBL] [Abstract][Full Text] [Related]
42. Modafinil for the treatment of daytime sleepiness in Parkinson's disease: a double-blind, randomized, crossover, placebo-controlled polygraphic trial. Högl B; Saletu M; Brandauer E; Glatzl S; Frauscher B; Seppi K; Ulmer H; Wenning G; Poewe W Sleep; 2002 Dec; 25(8):905-9. PubMed ID: 12489899 [TBL] [Abstract][Full Text] [Related]
43. Systemic exposure to armodafinil and its tolerability in healthy elderly versus young men: an open-label, multiple-dose, parallel-group study. Darwish M; Kirby M; Hellriegel ET; Yang R; Robertson P Drugs Aging; 2011 Feb; 28(2):139-50. PubMed ID: 21275439 [TBL] [Abstract][Full Text] [Related]
44. Effects of armodafinil and cognitive behavior therapy for insomnia on sleep continuity and daytime sleepiness in cancer survivors. Garland SN; Roscoe JA; Heckler CE; Barilla H; Gehrman P; Findley JC; Peoples AR; Morrow GR; Kamen C; Perlis ML Sleep Med; 2016 Apr; 20():18-24. PubMed ID: 27318221 [TBL] [Abstract][Full Text] [Related]
45. Efficacy and tolerability of a 20-mg dose of methylphenidate for the treatment of daytime sleepiness in adult patients with myotonic dystrophy type 1: a 2-center, randomized, double-blind, placebo-controlled, 3-week crossover trial. Puymirat J; Bouchard JP; Mathieu J Clin Ther; 2012 May; 34(5):1103-11. PubMed ID: 22578232 [TBL] [Abstract][Full Text] [Related]
47. Phase II double-blind placebo-controlled randomized study of armodafinil for brain radiation-induced fatigue. Page BR; Shaw EG; Lu L; Bryant D; Grisell D; Lesser GJ; Monitto DC; Naughton MJ; Rapp SR; Savona SR; Shah S; Case D; Chan MD Neuro Oncol; 2015 Oct; 17(10):1393-401. PubMed ID: 25972454 [TBL] [Abstract][Full Text] [Related]
48. Desvenlafaxine 50 and 100 mg/d in the treatment of major depressive disorder: an 8-week, phase III, multicenter, randomized, double-blind, placebo-controlled, parallel-group trial and a post hoc pooled analysis of three studies. Tourian KA; Padmanabhan SK; Groark J; Brisard C; Farrington D Clin Ther; 2009 Jun; 31 Pt 1():1405-23. PubMed ID: 19698901 [TBL] [Abstract][Full Text] [Related]
49. Placebo and modafinil effect on sleepiness in obstructive sleep apnea. Bittencourt LR; Lucchesi LM; Rueda AD; Garbuio SA; Palombini LO; Guilleminault C; Tufik S Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):552-9. PubMed ID: 18053628 [TBL] [Abstract][Full Text] [Related]
50. Shift work and the assessment and management of shift work disorder (SWD). Wright KP; Bogan RK; Wyatt JK Sleep Med Rev; 2013 Feb; 17(1):41-54. PubMed ID: 22560640 [TBL] [Abstract][Full Text] [Related]
51. Cognitive functioning of female nurses during the night shift: The impact of age, clock time, time awake and subjective sleepiness. Zion N; Shochat T Chronobiol Int; 2018 Oct; 35(11):1595-1607. PubMed ID: 30141975 [TBL] [Abstract][Full Text] [Related]
52. Double-Blind, Placebo-Controlled, Crossover Study of Armodafinil Treatment of Daytime Sleepiness Associated With Treated Nocturia. Krystal AD; Preud'homme XA Sleep; 2017 Jan; 40(1):. PubMed ID: 28364461 [TBL] [Abstract][Full Text] [Related]
53. A phase 3, double-blind, randomized, placebo-controlled study of armodafinil for excessive sleepiness associated with jet lag disorder. Rosenberg RP; Bogan RK; Tiller JM; Yang R; Youakim JM; Earl CQ; Roth T Mayo Clin Proc; 2010 Jul; 85(7):630-8. PubMed ID: 20530317 [TBL] [Abstract][Full Text] [Related]
54. Employees with shift work disorder experience excessive sleepiness also on non-work days: a cross-sectional survey linked to working hours register in Finnish hospitals. Vanttola P; Puttonen S; Karhula K; Oksanen T; HÄrmÄ M Ind Health; 2020 Aug; 58(4):366-374. PubMed ID: 32074541 [TBL] [Abstract][Full Text] [Related]
55. Armodafinil versus Modafinil in Patients of Excessive Sleepiness Associated with Shift Work Sleep Disorder: A Randomized Double Blind Multicentric Clinical Trial. Tembe DV; Dhavale A; Desai H; Mane DN; Raut SK; Dhingra G; Sardesai U; Saoji S; Rohra M; Shinde VG; Padsalge M; Paliwal A; Abbasi K; Devnani P; Papinwar S; Phadke S; Mehta H; Bhailume V Neurol Res Int; 2011; 2011():514351. PubMed ID: 21766023 [TBL] [Abstract][Full Text] [Related]
57. Building-site camps and extended work hours: A two-week monitoring of self-reported physical exertion, fatigue, and daytime sleepiness. Persson R; Helene Garde A; Schibye B; Ørbaek P Chronobiol Int; 2006; 23(6):1329-45. PubMed ID: 17190717 [TBL] [Abstract][Full Text] [Related]
58. Efficacy and safety of modafinil film-coated tablets in children and adolescents with attention-deficit/hyperactivity disorder: results of a randomized, double-blind, placebo-controlled, flexible-dose study. Biederman J; Swanson JM; Wigal SB; Kratochvil CJ; Boellner SW; Earl CQ; Jiang J; Greenhill L Pediatrics; 2005 Dec; 116(6):e777-84. PubMed ID: 16322134 [TBL] [Abstract][Full Text] [Related]
59. Pharmacokinetics of armodafinil and modafinil after single and multiple doses in patients with excessive sleepiness associated with treated obstructive sleep apnea: a randomized, open-label, crossover study. Darwish M; Kirby M; D'Andrea DM; Yang R; Hellriegel ET; Robertson P Clin Ther; 2010 Nov; 32(12):2074-87. PubMed ID: 21118743 [TBL] [Abstract][Full Text] [Related]
60. Efficacy and tolerability of escitalopram versus citalopram in major depressive disorder: a 6-week, multicenter, prospective, randomized, double-blind, active-controlled study in adult outpatients. Yevtushenko VY; Belous AI; Yevtushenko YG; Gusinin SE; Buzik OJ; Agibalova TV Clin Ther; 2007 Nov; 29(11):2319-32. PubMed ID: 18158074 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]